We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
Cap. Flow
-$362M
Cap. Flow %
-1.06%
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$283M
2
MDT icon
Medtronic
MDT
+$96M
3
PM icon
Philip Morris
PM
+$80.4M
4
UPS icon
United Parcel Service
UPS
+$75.5M
5
D icon
Dominion Energy
D
+$74.2M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$178M
2
GIS icon
General Mills
GIS
+$158M
3
XOM icon
ExxonMobil
XOM
+$138M
4
NOW icon
ServiceNow
NOW
+$96M
5
KEYS icon
Keysight
KEYS
+$72.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.14%
2 Financials 15.14%
3 Technology 13.55%
4 Consumer Discretionary 8.1%
5 Consumer Staples 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLT icon
1926
Bolt Biotherapeutics
BOLT
$7.76M
$3K ﹤0.01%
+107
New +$4.43K
CAE icon
1927
CAE Inc
CAE
$7.63B
$3K ﹤0.01%
+224
New +$4.79K
CASH icon
1928
Pathward Financial
CASH
$1.65B
$3K ﹤0.01%
84
+23
+38% +$826
COOK icon
1929
Traeger
COOK
$135M
$3K ﹤0.01%
+23
New +$3.88K
DASH icon
1930
DoorDash
DASH
$85.9B
$3K ﹤0.01%
58
-736
-93% -$49.2K
EZPW icon
1931
Ezcorp Inc
EZPW
$1.86B
$3K ﹤0.01%
349
-26
-7% -$215
FBRX
1932
DELISTED
Forte Biosciences
FBRX
$3K ﹤0.01%
131
-1
-0.8% -$32
CBIO
1933
Crescent Biopharma
CBIO
$698M
$3K ﹤0.01%
51
HP icon
1934
Helmerich & Payne
HP
$4.34B
$3K ﹤0.01%
86
-36
-30% -$1.51K
STRR
1935
Star Equity Holdings
STRR
$36.9M
$3K ﹤0.01%
80
+8
+11% +$260
MCS icon
1936
Marcus Corp
MCS
$843M
$3K ﹤0.01%
+249
New +$4.01K
MOFG
1937
DELISTED
MidWestOne Financial Group
MOFG
$3K ﹤0.01%
120
NGNE icon
1938
Neurogene
NGNE
$674M
$3K ﹤0.01%
215
+4
+2% +$82
PDSB icon
1939
PDS Biotechnology
PDSB
$42.4M
$3K ﹤0.01%
+1,035
New +$4.39K
RBCAA icon
1940
Republic Bancorp
RBCAA
$1.9B
$3K ﹤0.01%
76
SANM icon
1941
Sanmina
SANM
$10.3B
$3K ﹤0.01%
74
-11,957
-99% -$557K
TNK icon
1942
Teekay Tankers
TNK
$3.44B
$3K ﹤0.01%
+124
New +$2.93K
TPH
1943
DELISTED
Tri Pointe Homes
TPH
$3K ﹤0.01%
167
+59
+55% +$1.04K
TRUE
1944
DELISTED
TrueCar
TRUE
$3K ﹤0.01%
+1,755
New +$4K
VRM icon
1945
Vroom Inc
VRM
$53.1M
$3K ﹤0.01%
+29
New +$3.87K
ZIMV
1946
DELISTED
ZimVie
ZIMV
$3K ﹤0.01%
275
+203
+282% +$3.27K
CHS
1947
DELISTED
Chicos FAS, Inc.
CHS
$3K ﹤0.01%
352
-440
-56% -$2.45K
ALR
1948
DELISTED
AlerisLife Inc
ALR
$3K ﹤0.01%
2,730
+1,018
+59% +$1.17K
ATNX
1949
DELISTED
Athenex, Inc. Common Stock
ATNX
$3K ﹤0.01%
637
-70
-10% -$719
LCI
1950
DELISTED
Lannett Company, Inc.
LCI
$3K ﹤0.01%
1,882

Similar funds

Federated Hermes's Q3 2022 Portfolio in Review

As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.

  • Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
  • Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
  • Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
  • Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
  • Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
  • Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.

Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.